Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jordan W Smoller, S.D., M.D.

Co-Author

This page shows the publications co-authored by Jordan Smoller and Roy Perlis.
Connection Strength

6.696
  1. Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model. Psychol Med. 2012 Jan; 42(1):41-50.
    View in: PubMed
    Score: 0.471
  2. Genome-wide association study of suicide attempts in mood disorder patients. Am J Psychiatry. 2010 Dec; 167(12):1499-507.
    View in: PubMed
    Score: 0.451
  3. Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study. Neuropsychopharmacology. 2008 Nov; 33(12):2810-9.
    View in: PubMed
    Score: 0.374
  4. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry. 2007 Jun; 64(6):689-97.
    View in: PubMed
    Score: 0.356
  5. Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder. Biol Psychiatry. 2007 Sep 01; 62(5):536-40.
    View in: PubMed
    Score: 0.349
  6. Genetic validation of bipolar disorder identified by automated phenotyping using electronic health records. Transl Psychiatry. 2018 04 18; 8(1):86.
    View in: PubMed
    Score: 0.189
  7. Stratifying Risk for Renal Insufficiency Among Lithium-Treated Patients: An Electronic Health Record Study. Neuropsychopharmacology. 2016 Mar; 41(4):1138-43.
    View in: PubMed
    Score: 0.157
  8. Prevalence of Huntington's disease gene CAG trinucleotide repeat alleles in patients with bipolar disorder. Bipolar Disord. 2015 Jun; 17(4):403-8.
    View in: PubMed
    Score: 0.152
  9. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Mol Psychiatry. 2015 Jun; 20(6):727-34.
    View in: PubMed
    Score: 0.147
  10. An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry. 2014 Aug; 71(8):889-96.
    View in: PubMed
    Score: 0.146
  11. Contributions of the social environment to first-onset and recurrent mania. Mol Psychiatry. 2015 Mar; 20(3):329-36.
    View in: PubMed
    Score: 0.144
  12. Bipolar polygenic loading and bipolar spectrum features in major depressive disorder. Bipolar Disord. 2014 Sep; 16(6):608-16.
    View in: PubMed
    Score: 0.143
  13. Rare copy number variation in treatment-resistant major depressive disorder. Biol Psychiatry. 2014 Oct 01; 76(7):536-41.
    View in: PubMed
    Score: 0.141
  14. Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2013 Dec; 162B(8):779-88.
    View in: PubMed
    Score: 0.138
  15. QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ. 2013 Jan 29; 346:f288.
    View in: PubMed
    Score: 0.132
  16. Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder. Transl Psychiatry. 2012 Nov 13; 2:e184.
    View in: PubMed
    Score: 0.130
  17. Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study. Am J Psychiatry. 2012 Oct; 169(10):1065-72.
    View in: PubMed
    Score: 0.129
  18. Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants. BMJ Open. 2012; 2(2):e000544.
    View in: PubMed
    Score: 0.124
  19. Personality and bipolar disorder: dissecting state and trait associations between mood and personality. Psychol Med. 2011 Aug; 41(8):1593-604.
    View in: PubMed
    Score: 0.114
  20. Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. Am J Psychiatry. 2010 Oct; 167(10):1254-63.
    View in: PubMed
    Score: 0.111
  21. Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. Am J Psychiatry. 2010 May; 167(5):574-9.
    View in: PubMed
    Score: 0.108
  22. Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report. J Clin Psychiatry. 2010 Feb; 71(2):194-200.
    View in: PubMed
    Score: 0.107
  23. Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder. Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 05; 153B(1):303-9.
    View in: PubMed
    Score: 0.107
  24. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med. 2009 Dec 14; 169(22):2128-39.
    View in: PubMed
    Score: 0.106
  25. When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study. Neuropsychopharmacology. 2009 Sep; 34(10):2227-36.
    View in: PubMed
    Score: 0.102
  26. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry. 2009 Jun; 166(6):718-25.
    View in: PubMed
    Score: 0.102
  27. Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients. Neuropsychopharmacology. 2009 Jun; 34(7):1819-28.
    View in: PubMed
    Score: 0.101
  28. Association of a polymorphism near CREB1 with differential aversion processing in the insula of healthy participants. Arch Gen Psychiatry. 2008 Aug; 65(8):882-92.
    View in: PubMed
    Score: 0.097
  29. Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic model. J Clin Psychopharmacol. 2005 Oct; 25(5):427-34.
    View in: PubMed
    Score: 0.079
  30. Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHD. Biol Psychiatry. 2006 Mar 01; 59(5):460-7.
    View in: PubMed
    Score: 0.079
  31. The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder. J Affect Disord. 2004 Apr; 79(1-3):291-5.
    View in: PubMed
    Score: 0.071
  32. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry. 2003 Nov 01; 54(9):879-83.
    View in: PubMed
    Score: 0.069
  33. Transcriptome-based polygenic score links depression-related corticolimbic gene expression changes to sex-specific brain morphology and depression risk. Neuropsychopharmacology. 2021 12; 46(13):2304-2311.
    View in: PubMed
    Score: 0.060
  34. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021 06; 53(6):817-829.
    View in: PubMed
    Score: 0.059
  35. Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders. Biol Psychiatry. 2022 01 01; 91(1):102-117.
    View in: PubMed
    Score: 0.058
  36. The association between genetically determined ABO blood types and major depressive disorder. Psychiatry Res. 2021 05; 299:113837.
    View in: PubMed
    Score: 0.058
  37. Minimal phenotyping yields genome-wide association signals of low specificity for major depression. Nat Genet. 2020 04; 52(4):437-447.
    View in: PubMed
    Score: 0.054
  38. Translating Discoveries in Attention-Deficit/Hyperactivity Disorder Genomics to an Outpatient Child and Adolescent Psychiatric Cohort. J Am Acad Child Adolesc Psychiatry. 2020 08; 59(8):964-977.
    View in: PubMed
    Score: 0.052
  39. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019 05; 51(5):793-803.
    View in: PubMed
    Score: 0.051
  40. Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective Cases. Biol Psychiatry. 2019 07 15; 86(2):110-119.
    View in: PubMed
    Score: 0.050
  41. Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder. Front Psychiatry. 2018; 9:207.
    View in: PubMed
    Score: 0.048
  42. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018 05; 50(5):668-681.
    View in: PubMed
    Score: 0.047
  43. Genetic effects influencing risk for major depressive disorder in China and Europe. Transl Psychiatry. 2017 03 28; 7(3):e1074.
    View in: PubMed
    Score: 0.044
  44. Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder. Transl Psychiatry. 2017 01 10; 7(1):e993.
    View in: PubMed
    Score: 0.043
  45. An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype. Biol Psychiatry. 2017 09 01; 82(5):322-329.
    View in: PubMed
    Score: 0.043
  46. Predicting Suicidal Behavior From Longitudinal Electronic Health Records. Am J Psychiatry. 2017 Feb 01; 174(2):154-162.
    View in: PubMed
    Score: 0.042
  47. COMT Val(158) Met genotype is associated with reward learning: a replication study and meta-analysis. Genes Brain Behav. 2016 06; 15(5):503-13.
    View in: PubMed
    Score: 0.042
  48. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016 Mar 12; 387(10023):1085-1093.
    View in: PubMed
    Score: 0.041
  49. Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder. Mol Psychiatry. 2016 09; 21(9):1290-7.
    View in: PubMed
    Score: 0.040
  50. Extending the 'cross-disorder' relevance of executive functions to dimensional neuropsychiatric traits in youth. J Child Psychol Psychiatry. 2016 Apr; 57(4):462-71.
    View in: PubMed
    Score: 0.040
  51. Validation of electronic health record phenotyping of bipolar disorder cases and controls. Am J Psychiatry. 2015 Apr; 172(4):363-72.
    View in: PubMed
    Score: 0.038
  52. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013 Sep; 45(9):984-94.
    View in: PubMed
    Score: 0.034
  53. Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. PLoS One. 2013; 8(6):e65636.
    View in: PubMed
    Score: 0.034
  54. Feasibility of studying brain morphology in major depressive disorder with structural magnetic resonance imaging and clinical data from the electronic medical record: a pilot study. Psychiatry Res. 2013 Mar 30; 211(3):202-13.
    View in: PubMed
    Score: 0.032
  55. Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: a diffusion tensor imaging study using legacy data. World J Biol Psychiatry. 2014 Feb; 15(2):122-34.
    View in: PubMed
    Score: 0.031
  56. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry. 2013 Apr; 18(4):497-511.
    View in: PubMed
    Score: 0.031
  57. Modifiers and subtype-specific analyses in whole-genome association studies: a likelihood framework. Hum Hered. 2011; 72(1):10-20.
    View in: PubMed
    Score: 0.030
  58. A genome-wide association study of attempted suicide. Mol Psychiatry. 2012 Apr; 17(4):433-44.
    View in: PubMed
    Score: 0.029
  59. Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder. PLoS One. 2010 Nov 29; 5(11):e13945.
    View in: PubMed
    Score: 0.028
  60. Recurrent, robust and scalable patterns underlie human approach and avoidance. PLoS One. 2010 May 26; 5(5):e10613.
    View in: PubMed
    Score: 0.027
  61. The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology. 2010; 62(1):72-8.
    View in: PubMed
    Score: 0.027
  62. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry. 2011 Jan; 16(1):2-4.
    View in: PubMed
    Score: 0.027
  63. BDNF, relative preference, and reward circuitry responses to emotional communication. Am J Med Genet B Neuropsychiatr Genet. 2009 Sep 05; 150B(6):762-81.
    View in: PubMed
    Score: 0.026
  64. Dissecting the phenotype in genome-wide association studies of psychiatric illness. Br J Psychiatry. 2009 Aug; 195(2):97-9.
    View in: PubMed
    Score: 0.026
  65. Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry. 2009 Apr; 14(4):359-75.
    View in: PubMed
    Score: 0.025
  66. Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse? Neuron. 2008 Oct 09; 60(1):174-88.
    View in: PubMed
    Score: 0.024
  67. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008 Sep; 40(9):1056-8.
    View in: PubMed
    Score: 0.024
  68. Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008 Jun; 13(6):558-69.
    View in: PubMed
    Score: 0.023
  69. Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder. Am J Med Genet B Neuropsychiatr Genet. 2007 Sep 05; 144B(6):781-90.
    View in: PubMed
    Score: 0.023
  70. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder. Arch Gen Psychiatry. 2007 Feb; 64(2):209-14.
    View in: PubMed
    Score: 0.022
  71. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 Jun 01; 57(11):1313-23.
    View in: PubMed
    Score: 0.019
  72. Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. J Psychiatr Res. 2003 May-Jun; 37(3):187-92.
    View in: PubMed
    Score: 0.017
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.